Matteo Lusardi, Nicoletta Basilico, Erika Iervasi, Chiara Brullo, Silvia Parapini, Marco Ponassi, Camillo Rosano, Andrea Spallarossa
{"title":"高取代吡唑和嘧啶衍生物的抗原虫活性。","authors":"Matteo Lusardi, Nicoletta Basilico, Erika Iervasi, Chiara Brullo, Silvia Parapini, Marco Ponassi, Camillo Rosano, Andrea Spallarossa","doi":"10.1002/cmdc.202500154","DOIUrl":null,"url":null,"abstract":"<p><p>To further extend the structure-activity relationships of previously reported antimalarial anilino-pyrazoles VI, trisubstituted pyrazoles 13-15 and pyrimidines 16 and 17 were designed and synthesized. The novel derivatives were prepared thorough a divergent, chemo-selective approach starting from N,S-acetal intermediates. Compounds 13-17 were tested for their antimalarial and antileishmanial activity and their cytotoxicity was evaluated against human fibroblast. Pyrazoles 14d,e and pyrimidine 17e were identified as novel and effective antiplasmodial agents being able to inhibit, at micromolar concentrations, chloroquine(CQ)-sensitive and CQ-resistant Plasmodium falciparum strains as well as Leishmania infatum and Leishmania tropica protozoa. Additionally, favourable pharmacokinetics and toxicity profiles were predicted for the compounds.</p>","PeriodicalId":147,"journal":{"name":"ChemMedChem","volume":" ","pages":"e202500154"},"PeriodicalIF":3.6000,"publicationDate":"2025-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Antiprotozoal activity of highly substituted pyrazole and pyrimidine derivates.\",\"authors\":\"Matteo Lusardi, Nicoletta Basilico, Erika Iervasi, Chiara Brullo, Silvia Parapini, Marco Ponassi, Camillo Rosano, Andrea Spallarossa\",\"doi\":\"10.1002/cmdc.202500154\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>To further extend the structure-activity relationships of previously reported antimalarial anilino-pyrazoles VI, trisubstituted pyrazoles 13-15 and pyrimidines 16 and 17 were designed and synthesized. The novel derivatives were prepared thorough a divergent, chemo-selective approach starting from N,S-acetal intermediates. Compounds 13-17 were tested for their antimalarial and antileishmanial activity and their cytotoxicity was evaluated against human fibroblast. Pyrazoles 14d,e and pyrimidine 17e were identified as novel and effective antiplasmodial agents being able to inhibit, at micromolar concentrations, chloroquine(CQ)-sensitive and CQ-resistant Plasmodium falciparum strains as well as Leishmania infatum and Leishmania tropica protozoa. Additionally, favourable pharmacokinetics and toxicity profiles were predicted for the compounds.</p>\",\"PeriodicalId\":147,\"journal\":{\"name\":\"ChemMedChem\",\"volume\":\" \",\"pages\":\"e202500154\"},\"PeriodicalIF\":3.6000,\"publicationDate\":\"2025-06-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ChemMedChem\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1002/cmdc.202500154\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ChemMedChem","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/cmdc.202500154","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
摘要
为了进一步扩展先前报道的抗疟疾苯胺吡唑VI的构效关系,设计并合成了三取代吡唑13-15和嘧啶16和17。从N, s -缩醛中间体开始,通过发散的化学选择性方法制备了新的衍生物。测定了化合物13 ~ 17的抗疟和抗利什曼原虫活性,并对其对人成纤维细胞的细胞毒性进行了评价。吡唑14d、e和嘧啶17e是一种新型有效的抗疟原虫药物,在微摩尔浓度下能抑制氯喹敏感和耐氯喹的恶性疟原虫菌株以及利什曼原虫和热带利什曼原虫。此外,预测这些化合物具有良好的药代动力学和毒性。
Antiprotozoal activity of highly substituted pyrazole and pyrimidine derivates.
To further extend the structure-activity relationships of previously reported antimalarial anilino-pyrazoles VI, trisubstituted pyrazoles 13-15 and pyrimidines 16 and 17 were designed and synthesized. The novel derivatives were prepared thorough a divergent, chemo-selective approach starting from N,S-acetal intermediates. Compounds 13-17 were tested for their antimalarial and antileishmanial activity and their cytotoxicity was evaluated against human fibroblast. Pyrazoles 14d,e and pyrimidine 17e were identified as novel and effective antiplasmodial agents being able to inhibit, at micromolar concentrations, chloroquine(CQ)-sensitive and CQ-resistant Plasmodium falciparum strains as well as Leishmania infatum and Leishmania tropica protozoa. Additionally, favourable pharmacokinetics and toxicity profiles were predicted for the compounds.
期刊介绍:
Quality research. Outstanding publications. With an impact factor of 3.124 (2019), ChemMedChem is a top journal for research at the interface of chemistry, biology and medicine. It is published on behalf of Chemistry Europe, an association of 16 European chemical societies.
ChemMedChem publishes primary as well as critical secondary and tertiary information from authors across and for the world. Its mission is to integrate the wide and flourishing field of medicinal and pharmaceutical sciences, ranging from drug design and discovery to drug development and delivery, from molecular modeling to combinatorial chemistry, from target validation to lead generation and ADMET studies. ChemMedChem typically covers topics on small molecules, therapeutic macromolecules, peptides, peptidomimetics, and aptamers, protein-drug conjugates, nucleic acid therapies, and beginning 2017, nanomedicine, particularly 1) targeted nanodelivery, 2) theranostic nanoparticles, and 3) nanodrugs.
Contents
ChemMedChem publishes an attractive mixture of:
Full Papers and Communications
Reviews and Minireviews
Patent Reviews
Highlights and Concepts
Book and Multimedia Reviews.